ConSynance`s CSTI-500 Gets FDA Rare Pediatric Disease Designation
24 Jul 2024 //
GLOBENEWSWIRE
Positive Phase I results for Prader-Willi Syndrome drug
31 May 2023 //
CLINICAL TRIALS ARENA
ConSynance Reports Positive Phase 1 Results for CSTI-500
30 May 2023 //
GLOBENEWSWIRE